Celsius Holdings, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K, dated May 28, 2025, details the results of the Annual Meeting of Stockholders held on that date. The filing covers corporate governance actions, including the election of directors, approval of compensation plans, and amendments to the Articles of Incorporation.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. It is a corporate governance report rather than a financial results statement.
Material Changes and Corporate Actions
- Authorized Share Increase: Stockholders approved an amendment to the Articles of Incorporation, increasing authorized Common Stock from 300,000,000 to 400,000,000 shares. The amendment was filed with the State of Nevada and became effective on May 28, 2025.
- Compensation Plans Approved:
- 2025 Omnibus Incentive Compensation Plan: Approved to issue up to 6,000,000 shares of Common Stock.
- 2025 Employee Stock Purchase Plan (ESPP): Approved to issue up to 850,000 shares of Common Stock.
- Director Elections: All nine nominees were elected to the Board of Directors. Notable voting results included significant "Against" votes for Nick Castaldo (46,976,938), Damon DeSantis (72,192,302), Caroline Levy (46,859,620), and Cheryl Miller (46,849,782), though all nominees received majority support.
- Executive Compensation: Stockholders approved the "Say on Pay" resolution and voted to conduct future advisory votes on executive compensation frequency every 1 year.
- Auditor Ratification: The appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025, was ratified.
Guidance, Outlook, and Risks
The filing does not provide management commentary on business outlook, financial guidance, specific risks, or contingencies. It strictly reports on the voting outcomes of the Annual Meeting.
Key Facts for Investor Verification
- Verify the impact of the increased authorized share count (400,000,000) on potential future dilution.
- Review the specific terms of the newly approved 2025 Omnibus Plan and 2025 ESPP in the definitive proxy statement filed on April 14, 2025.
- Analyze the significant "Against" votes for four specific director nominees to understand shareholder sentiment regarding board composition.
- Confirm the effective date of the Articles of Incorporation amendment (May 28, 2025) for corporate record purposes.